{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:31:18Z","timestamp":1793356278744,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lanwpc.2026.101991","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:35:55Z","timestamp":1790282155000},"page":"101991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Trends and disparities in hepatitis B burden in the Western Pacific Region, 2015\u20132024: a subregional analysis using modelled data"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6876-8313","authenticated-orcid":false,"given":"Hsu Thinzar","family":"Maung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0454-3339","authenticated-orcid":false,"given":"Mohamed Amine","family":"Ghrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukushi","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra Prasad","family":"Hubraj Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong Thi","family":"Giang Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohiko","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2026.101991_bib1","series-title":"Global Hepatitis Report 2026: Efforts to Eliminate Hepatitis Deliver Gains but More Action Needed to Meet 2030 Targets","year":"2026"},{"key":"10.1016\/j.lanwpc.2026.101991_bib2","series-title":"Global Health Sectors Strategy on Viral Hepatitis 2016-2021: Towards Ending Viral Hepatitis","year":"2016"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101991_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/vaccines12030288","article-title":"Global perspectives on the hepatitis B vaccination: challenges, achievements, and the road to elimination by 2030","volume":"12","author":"Al-Busafi","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101991_bib4","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lanwpc.2026.101991_bib5","series-title":"Preventing Perinatal Hepatitis B Virus Transmission : a Guide for Introducing and Strengthening Hepatitis B Birth Dose Vaccination","year":"2015"},{"issue":"9","key":"10.1016\/j.lanwpc.2026.101991_bib8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanwpc.2026.101991_bib9","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81070","article-title":"The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda","volume":"12","author":"Martyn","year":"2023","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.lanwpc.2026.101991_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","volume":"8","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101991_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanwpc.2026.101991_bib12","series-title":"Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries","year":"2024"},{"issue":"10062","key":"10.1016\/j.lanwpc.2026.101991_bib13","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101991_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2026.2641857","article-title":"Global, regional, and national burden of chronic hepatitis B, 1990-2021, and projections to 2030: an urgent call for action to achieve hepatitis B elimination goals by 2030","volume":"22","author":"Shen","year":"2026","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101991_bib17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1440-1746.2005.03813.x","article-title":"Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression","volume":"20","author":"Lin","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.lanwpc.2026.101991_bib18","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41575-024-00967-4","article-title":"Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions","volume":"21","author":"Mak","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.lanwpc.2026.101991_bib19","article-title":"Burden of hepatitis B virus-associated liver cancer in Asia: findings from the global burden of disease study","volume":"14","author":"Yang","year":"2026","journal-title":"Front Public Health"},{"key":"10.1016\/j.lanwpc.2026.101991_bib20","series-title":"Guidelines for the Prevention, Diagnosis, Care and Treatment for People with Chronic Hepatitis B Infection","year":"2024"},{"issue":"1\u20132","key":"10.1016\/j.lanwpc.2026.101991_bib21","first-page":"47","article-title":"Barriers to the delivery of the hepatitis B birth dose: a study of five Papua New Guinean hospitals in 2007","volume":"51","author":"Downing","year":"2008","journal-title":"P N G Med J"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101991_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.vaccine.2015.11.044","article-title":"Assessment of the hepatitis B birth dose vaccination program, Papua New Guinea, 2014","volume":"34","author":"Wiesen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.lanwpc.2026.101991_bib23","article-title":"High rates of hepatitis B vertical transmission in Kiribati: a warning sign for meeting 2030 WHO elimination targets in the Pacific Islands?","volume":"60","author":"Lee","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101991_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21037\/hbsn-2024-754","article-title":"2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challenges","volume":"14","author":"Yan","year":"2025","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"9","key":"10.1016\/j.lanwpc.2026.101991_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae483","article-title":"Impact of hepatitis B virus point-of-care DNA viral load testing compared with laboratory-based standard-of-care approaches on uptake of HBV viral load testing, treatment, and turnaround times: a systematic review and meta-analysis","volume":"11","author":"Gu","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.lanwpc.2026.101991_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01405-25","article-title":"Evaluation of fingerstick blood point-of-care testing of hepatitis B DNA for enhanced hepatitis B treatment decision making: a diagnostic accuracy study","volume":"64","author":"Hajarizadeh","year":"2026","journal-title":"J Clin Microbiol"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526001951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526001951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:31:33Z","timestamp":1793352693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606526001951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":22,"alternative-id":["S2666606526001951"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101991","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends and disparities in hepatitis B burden in the Western Pacific Region, 2015\u20132024: a subregional analysis using modelled data","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101991"}}